JTT-705

· Akros Pharma Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JTT-705, covering 2008-05-29 to 2008-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels [Phase 2]

See pricing